Detalhe da pesquisa
1.
Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics.
Nephrol Dial Transplant;
35(10): 1721-1729, 2020 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31157889
2.
Response to: 'Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease' by Campochiaro et al.
Ann Rheum Dis;
81(1): e12, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31959593
3.
Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter.
Ann Rheum Dis;
79(11): e148, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31285257
4.
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
Ann Rheum Dis;
79(6): 837-839, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32332072
5.
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
Blood;
121(9): 1495-500, 2013 Feb 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23258922
6.
Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).
Blood;
130(11): 1377-1380, 2017 09 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28667012
7.
Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.
Br J Haematol;
180(1): 150-153, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27711968
8.
Efficacy of infliximab in the treatment of Erdheim-Chester disease.
Ann Rheum Dis;
77(9): 1387-1390, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29363511
9.
Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical application.
J Pharm Biomed Anal;
236: 115730, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37734255
10.
Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation.
Front Immunol;
13: 790334, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35222375
11.
Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome.
J Rheumatol;
47(6): 896-902, 2020 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31371658
12.
Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.
J Neurol;
266(5): 1073-1078, 2019 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30739183
13.
Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy.
Neurol Clin Pract;
11(3): e376-e378, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34484921
14.
Acute Pancreatitis From Treatment With BRAF Inhibitors in Erdheim-Chester Disease: A Report From 2 Tertiary Referral Centers.
Pancreas;
50(1): e6-e8, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33370037
15.
Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.
J Clin Oncol;
33(5): 411-8, 2015 Feb 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25422482
16.
Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease.
Neurology;
83(14): 1294-6, 2014 Sep 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25171932
17.
Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.
Neurology;
83(16): 1478-80, 2014 Oct 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25209580